JP2023047226A5 - - Google Patents

Download PDF

Info

Publication number
JP2023047226A5
JP2023047226A5 JP2021156188A JP2021156188A JP2023047226A5 JP 2023047226 A5 JP2023047226 A5 JP 2023047226A5 JP 2021156188 A JP2021156188 A JP 2021156188A JP 2021156188 A JP2021156188 A JP 2021156188A JP 2023047226 A5 JP2023047226 A5 JP 2023047226A5
Authority
JP
Japan
Prior art keywords
mbbt
tinosorb
confirmed
blending amount
spf value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021156188A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023047226A (ja
JP7825961B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2021156188A priority Critical patent/JP7825961B2/ja
Priority claimed from JP2021156188A external-priority patent/JP7825961B2/ja
Publication of JP2023047226A publication Critical patent/JP2023047226A/ja
Publication of JP2023047226A5 publication Critical patent/JP2023047226A5/ja
Application granted granted Critical
Publication of JP7825961B2 publication Critical patent/JP7825961B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021156188A 2021-09-24 2021-09-24 皮膚外用剤 Active JP7825961B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021156188A JP7825961B2 (ja) 2021-09-24 2021-09-24 皮膚外用剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2021156188A JP7825961B2 (ja) 2021-09-24 2021-09-24 皮膚外用剤

Publications (3)

Publication Number Publication Date
JP2023047226A JP2023047226A (ja) 2023-04-05
JP2023047226A5 true JP2023047226A5 (cg-RX-API-DMAC7.html) 2024-09-17
JP7825961B2 JP7825961B2 (ja) 2026-03-09

Family

ID=85778461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021156188A Active JP7825961B2 (ja) 2021-09-24 2021-09-24 皮膚外用剤

Country Status (1)

Country Link
JP (1) JP7825961B2 (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009040917A1 (ja) * 2007-09-27 2009-04-02 Lead Chemical Co. , Ltd. 紫外線吸収剤
US8691191B2 (en) * 2008-10-31 2014-04-08 Shiseido Company, Ltd. O/W emulsified composition
JP2011236199A (ja) * 2010-04-13 2011-11-24 Shiseido Co Ltd 水中油型乳化組成物
JP6029822B2 (ja) * 2011-11-25 2016-11-24 ポーラ化成工業株式会社 水中油型乳化組成物
JP2020007279A (ja) * 2018-07-11 2020-01-16 株式会社成和化成 水中油型乳化化粧料

Similar Documents

Publication Publication Date Title
JP2021518134A5 (cg-RX-API-DMAC7.html)
CN111757878A (zh) 一种哒嗪类衍生物抑制剂、其制备方法和应用
CN112469713A (zh) 芳基磷氧化物类衍生物抑制剂、其制备方法和应用
CN108026053A8 (zh) 作为mIDH1抑制剂的稠合的咪唑类化合物
JP2023517948A5 (cg-RX-API-DMAC7.html)
CN107995862B8 (zh) 包含sglt-2抑制剂之液态药物组合物
CN101687022A8 (zh) Prame衍生的肽以及包括该肽的免疫原组合物
EP3818972A3 (en) Piroctone olamine granules for use in cosmetic compositions
MY204940A (en) Compositions
MA41072A1 (fr) Nouvelles protéines spécifiques de la pyoverdine et de la pyochéline
JP2018203763A5 (cg-RX-API-DMAC7.html)
JP2021005080A5 (cg-RX-API-DMAC7.html)
CN109415361A (zh) 丙烯酸类衍生物及其制备方法和其在医药上的用途
CN113906026A (zh) 作为atr激酶抑制剂的2,4,6-三取代的嘧啶化合物
JP2021528391A5 (cg-RX-API-DMAC7.html)
JP2005529145A5 (cg-RX-API-DMAC7.html)
CN110382490A (zh) 喹唑啉类化合物及其制备方法、用途和药物组合物
PH12013500251A1 (en) Oral care compositions
CN111406050A (zh) 吲哚胺2,3-双加氧酶抑制剂及其用途
JP2023047226A5 (cg-RX-API-DMAC7.html)
CN111741946A (zh) 吲哚胺2,3-双加氧酶抑制剂以及它们在医学上的应用
CN111868057A (zh) 一种二氢嘧啶类化合物的固体形式及其制备方法和用途
JP2018504513A5 (cg-RX-API-DMAC7.html)
JPWO2021025047A5 (cg-RX-API-DMAC7.html)
JP2015030778A5 (cg-RX-API-DMAC7.html)